The nurse should question an order for bismuth salts for a client with what condition?

Choice A.Isoetharine is a bronchodilator that works by relaxing muscles in the airways to improve breathing. It is not a mast cell stabilizer.

Choice B is wrong because aminophylline is a bronchodilator that relaxes the muscles in the airways and is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is not a mast cell stabilizer.

Choice C is wrong becauseIpratropium is an anticholinergic bronchodilator that helps to open up the airways in the lungs. It is used in the treatment of COPD and sometimes asthma, but it is not a mast cell stabilizer.

Choice D. Cromolyn is a mast cell stabilizer that helps prevent the release of substances in the body that cause inflammation and asthma symptoms. It is used for the prevention of asthma attacks and is particularly effective in managing exercise-induced asthma and allergic asthma triggers.

Glulisine is a rapid-acting insulin that has an onset of action of 2 to 5 minutes and peaks in 30 to 90 minutes, making it the fastest among the choices. Some possible explanations for the other choices are:

Choice A. Aspart is also a rapid-acting insulin, but it has a slightly longer onset of action (10 to 20 minutes) and peak time (1 to 3 hours) than glulisine.

Choice B. Lispro is another rapid-acting insulin, but it has a similar onset of action (<15 minutes) and peak time (30 to 90 minutes) as glulisine, so it is not the fastest.

Choice C. Regular is a short-acting insulin that has a much longer onset of action (30 to 60 minutes) and peak time (2 to 4 hours) than glulisine, so it is not suitable for fast therapeutic effects.

Normal ranges for blood glucose levels are 70 to 130 mg/dL before meals and less than 180 mg/dL after meals.

Insulin doses are adjusted based on blood glucose monitoring, carbohydrate intake, physical activity, and other factors.